Tharimmune
Biotechnology company(THAR)Similar Projects
*If it’s not clickable, it means no detailed information is available.
The Ether Machine
Ethereum Yield and Infrastructure Company(Nasdaq:ETHM)
Fold
Bitcoin Financial Services Company(NASDAQ: FLD) 
H100 Group
Health technology and investment consulting（NGM：H100）
Rumble
Decentralized Video Streaming (Nasdaq: RUM)
Quantum Solutions
AI technology listed company(TSE: 2338.T)
GameStop
Game Seller (NYSE:GME)
BTC Digital
Cryptocurrency Technology Corporation（Nasdaq：BTCT）
DV8 Public Company Limited
Advertising Media(SET:DV8)About Tharimmune
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Investors
Liberty City Ventures
DRW Venture Capital
Kraken
PolychainA
ARK InvestFundrasing details
| Funding Round | Amount | Valuation | Date | Investors |
|---|---|---|---|---|
Post-IPO | $540.00M | -- | 2025-11-03 |  Liberty City Ventures* DRW Venture Capital*+ 3 |